The Novel HLA ‐E Allele, HLA ‐E*01:151, Identified in a Chinese Individual
HLA · 2024
DOI: 10.1111/tan.15773 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Lina Dong und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: Histocompatibility Antigens Class I, HLA-E Antigens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: Science Research Foundation of Zhejiang Healthy Bureau.
Abstract (Originalsprache)
HLA‐E*01:151 differs from HLA‐E*01:03:01:01 by a single nucleotide substitution at position 890 C>T in exon 5.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
- Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
- Institute of Hematology, Zhejiang University, Hangzhou, China.
- Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.
ORCID-Profile: Lina Dong, Yanmin He, Faming Zhu
Förderung
- Science Research Foundation of Zhejiang Healthy Bureau
Zitieren
APA
Dong, L., He, Y., Yang, L., He, Y., & Zhu, F. (2024). The Novel HLA ‐E Allele, HLA ‐E*01:151, Identified in a Chinese Individual. HLA. https://doi.org/10.1111/tan.15773
Vancouver
Dong L, He Y, Yang L, He Y, Zhu F. The Novel HLA ‐E Allele, HLA ‐E*01:151, Identified in a Chinese Individual. HLA. 2024. doi:10.1111/tan.15773
BibTeX
@article{Dong2024,
author = {Dong, Lina and He, Yanmin and Yang, Luxin and He, Yizhen and Zhu, Faming},
title = {The Novel HLA ‐E Allele, HLA ‐E*01:151, Identified in a Chinese Individual},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15773}
}
EUVIMED